Waterloo, Canada

John E Thompson

This inventor holds 32 USPTO granted patents and 21 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Senesco Technologies, Inc., Senesco, Inc., Agribody Technologies, Inc.. Active years: 2003-2021.

USPTO Granted Patents = 32 

% Patents Active = 40.6

 

 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Deoxyhypusine Synthase
Eukaryotic Initiation Factor 5A
siRNA Therapeutics
Apoptosis Modulation
Transgenic Plants
Polynucleotide Compositions
Cytokine Regulation
Plant Senescence Control
Gene Expression Suppression
Anti-Inflammatory Therapeutics
Nucleic Acid Technologies
Plant Biotechnology
32 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John E. Thompson

Introduction

John E. Thompson, an accomplished inventor based in Waterloo, Canada, has made significant strides in the field of plant genetics and biotechnology. With an impressive portfolio of 32 patents, Thompson's work addresses critical challenges in plant biology and therapeutics. His inventions not only showcase his skills as an inventor but also contribute to advancements in agricultural practices and medical therapies.

Latest Patents

Among Thompson's latest patents are groundbreaking inventions focused on enhancing plant longevity and combating apoptosis-related diseases. One notable patent involves the development of plants with modified deoxyhypusine synthase genes. This invention describes methods to produce plants that exhibit delayed senescence through genetic alterations. Specifically, the methods induce nucleotide deletions, insertions, or substitutions in the gene encoding deoxyhypusine synthase (DHS), leading to decreased DHS activity and prolonged plant vitality.

Another recent invention from Thompson relates to the inhibition of apoptosis-specific eIF-5A using antisense oligonucleotides and siRNA as anti-inflammatory therapeutics. This patent adds to his portfolio by detailing new approaches to suppress apoptosis in cells, leveraging the unique properties of the eucaryotic initiation factor 5A (eIF-5A). By utilizing these advanced methods, the invention aims to inhibit pro-inflammatory cytokines and reduce the activation of NFkB, presenting promising applications for managing inflammatory conditions.

Career Highlights

Thompson's professional journey includes significant contributions while collaborating with esteemed organizations. Notably, he has been associated with Senesco Technologies, Inc. and Senesco, Inc., where he applied his expertise in biotechnology to drive innovative research. His career reflects a commitment to pushing the boundaries of scientific knowledge and enhancing practical applications of his inventions.

Collaborations

Throughout his illustrious career, John E. Thompson has collaborated with prominent researchers, including Tzann-Wei Wang and Dongen Lily Lu. These collaborations underscore the importance of teamwork in advancing research and the collective effort required to bring innovative solutions to fruition. The synergy between Thompson and his colleagues has undoubtedly fueled many of his successful inventions.

Conclusion

John E. Thompson represents the spirit of innovation within the realms of plant genetics and therapeutics. With a robust portfolio of patents and collaborative efforts that reflect a proactive approach to scientific challenges, Thompson's contributions continue to influence both agricultural and medical fields. His work serves as an inspiration to aspiring inventors who aim to create impactful solutions that benefit society as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…